Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 5 Distribution of LVEF % by experimental treatment groups

From: In-hospital measurement of left ventricular ejection fraction and one-year outcomes in acute coronary syndromes: results from the IMMEDIATE Trial

Variable GIK,
Mean (SD)
Median LVEF%, (N)
Placebo
Mean (SD)
Median LVEF%, (N)
P value for Mean
LVEF (Catheterization and Echocardiogram) 48.6 (14)
50 (207)
46.2 (14)
45 (238)
0.07
LVEF (Catheterization) 49.3 (14)
50 (120)
48.3 (14)
50 (153)
0.33
LVEF (Echocardiogram) 47.6 (14)
50 (87)
43.6 (14)
45 (85)
0.08
LVEF (Earlya) 49.2 (13)
50 (110)
47.4 (13)
50 (138)
0.27
LVEF (Not earlyb) 47.8 (15)
50 (97)
44.6 (15)
45 (100)
0.13
  1. aEarly when the LVEF was measured within 0 days of ED arrival
  2. bNot early when LVEF was measured 1 or more days after ED arrival or with unknown dates